Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Durrant

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucinL G Durrant, E Jacobs, M R Price
International Journal of Cancer|January 15, 1990
The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45GS A Watson, L G Durrant, D L Morris
Carcinogenesis|January 1, 1981
Effects of 5-methylnicotinamide on mouse L1210 cells exposed to N-methyl-N-nitrosourea: mutation induction, formation and removal of methylation products in DNA, and unscheduled DNA synthesisL G Durrant, G P Margison, J M Boyle
British Journal of Obstetrics and Gynaecology|July 1, 1998
Non-invasive fetal cell isolation from maternal bloodW L Martin, L G Durrant, D T Liu
European Journal of Cancer & Clinical Oncology|September 1, 1989
Influence of circulating antigen on the biodistribution and tumour localization of radiolabelled monoclonal antibody in a human tumour: nude mouse xenograft modelM V Pimm, L G Durrant, R W Baldwin
Journal of the National Cancer Institute|May 3, 1989
Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancerL G Durrant, R A Robins, R W Baldwin
Human Antibodies and Hybridomas|January 1, 1995
Clinical evidence that the human monoclonal anti-idiotypic antibody 105AD7, delays tumor growth by stimulating anti-tumor T-cell responsesD T Buckley, A R Robins, L G Durrant
Cancer Research|May 27, 1999
Decay accelerating factor (CD55): a target for cancer vaccines?I Spendlove, L Li, J Carmichael, et al.
British Journal of Cancer|January 5, 2001
CD55 is over-expressed in the tumour environmentL Li, I Spendlove, J Morgan, et al.
The British Journal of Surgery|April 1, 1988
Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitroS A Watson, L G Durrant, D L Morris
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucinL G Durrant, E Jacobs, M R Price
International Journal of Cancer|January 15, 1990
The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45GS A Watson, L G Durrant, D L Morris
Carcinogenesis|January 1, 1981
Effects of 5-methylnicotinamide on mouse L1210 cells exposed to N-methyl-N-nitrosourea: mutation induction, formation and removal of methylation products in DNA, and unscheduled DNA synthesisL G Durrant, G P Margison, J M Boyle
British Journal of Obstetrics and Gynaecology|July 1, 1998
Non-invasive fetal cell isolation from maternal bloodW L Martin, L G Durrant, D T Liu
European Journal of Cancer & Clinical Oncology|September 1, 1989
Influence of circulating antigen on the biodistribution and tumour localization of radiolabelled monoclonal antibody in a human tumour: nude mouse xenograft modelM V Pimm, L G Durrant, R W Baldwin
Journal of the National Cancer Institute|May 3, 1989
Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancerL G Durrant, R A Robins, R W Baldwin
Human Antibodies and Hybridomas|January 1, 1995
Clinical evidence that the human monoclonal anti-idiotypic antibody 105AD7, delays tumor growth by stimulating anti-tumor T-cell responsesD T Buckley, A R Robins, L G Durrant
Cancer Research|May 27, 1999
Decay accelerating factor (CD55): a target for cancer vaccines?I Spendlove, L Li, J Carmichael, et al.
British Journal of Cancer|January 5, 2001
CD55 is over-expressed in the tumour environmentL Li, I Spendlove, J Morgan, et al.
The British Journal of Surgery|April 1, 1988
Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitroS A Watson, L G Durrant, D L Morris
Pageof 9